Nearly 20K cancer patients at NYC's Memorial Sloan Kettering at risk of losing critical care over insurance spat
The two sides have until the end of June to hash out a new deal over reimbursement rates — but are trading blame while patients, many in need of lifesaving care, anxiously wait to see if they will keep in-network treatment.
Patient Lee Kassler, of Plainview, Long Island, said he was in 'disbelief' and 'shocked' when he found out that he could lose care on July 1 if the Manhattan hospital and health insurance company don't reach an agreement by June 30.
'Full of anxiety, full of stress, saddened, angry, worried, just a whole host of emotions that I was faced with when I was diagnosed with cancer,' Kassler, who has had a rare, incurable gastric cancer since 2022, told The Post Friday.
The new grandfather, 61, said he goes to MSK with '110 percent' confidence, and couldn't imagine using another medical center for his 'life and death situation.'
MSK officials have been pushing for a higher reimbursement rate for services, claiming the current yearly increase of 1.6% over the last five years isn't on par with rising costs the hospital is facing.
'MSK has worked hard to reach a long-term agreement with UHC — one that reflects the real cost and value of our specialized cancer care,' the hospital said in a statement. 'UHC refused to agree to that.'
But UHC argued that the top-rated cancer treatment center is pushing a 35% spike in reimbursement rates over the next three years — which could cost the health insurance provider nearly $470 million.
Memorial Sloan Kettering says UnitedHealthcare needs to increase the reimbursement.
Christopher Sadowski
'Our top priority is to reach an agreement with MSK that is affordable for consumers and employers,' the company, which also covers Oxford plans, said in a statement to The Post.
'We have proposed meaningful rate increases that would continue to reimburse MSK at levels significantly higher than other National Cancer Institute-designated health systems in the New York City metro area.'
The company, whose CEO Brian Thompson was fatally shot by alleged gunman Luigi Mangione last year, has also publicly worked to make its case to consumers.
MSK chief medical officer Cardinale Smith, meanwhile, argued in an interview the proposal from the health insurer is not financially sustainable.
UnitedHealthcare claims MSK's demands are too high.
Getty Images
'Bottom line is that there are thousands of patients who need our care and UHC is just not putting them first,' Smith said.
About 19,225 patients, including Kassler, could have treatment disrupted, hospital reps said.
Sloan Kettering has gotten into past contract fights with Anthem and Cigna before deals were reached.
Even if a new agreement with UHC isn't inked by June 30, a New York state law requires a cooling-off period in which at least some patients will get in-network care at the hospital through the end of August.
The grace period applies to patients with fully insured UnitedHealthcare or Oxford plans for hospital care, both MSK and the health insurer said.
Patients can also apply for continuity of care that would possibly give them a temporary extension of in-network treatment.
With his birthday coming up in a few days, Kassler said all he wants is to receive news of a deal.
'The best birthday present was my grandson but the second best would be let's put this behind us,' Kassler said.
'Let me just be under the treatment of Sloan for a long time.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The endometrium, the inner lining of the uterus, is the layer of tissue that thickens every month in preparation for a possible pregnancy. But just as a baby can grow there, so can nasty cancer cells. Endometrial cancer, also called uterine cancer, is diagnosed in over 69,000 women every year, per the National Cancer Institute. And since there's no screening test to catch it, knowing and recognizing the signs of endometrial cancer is key to early detection. "Pap tests don't check for or find endometrial cancer, and most women who get it have normal Paps," said Nita Karnik Lee, M.D., associate professor of obstetrics and gynecology at the University of Chicago Medicine. That's why it's important to know the risk factors. According to the Mayo Clinic, these include taking estrogen-only hormones, starting your period before age 12 or beginning menopause late, never having been pregnant, being obese, being menopause age or post-menopausal, and taking the breast cancer medication tamoxifen. Meet the expert: Nita Karnik Lee, M.D., associate professor of obstetrics and gynecology at the University of Chicago Medicine. But the most important thing you can do, really, is to know the warning signs. Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in early detection and treatment. Here are some worth bringing to your doc's attention: 1. Unusual vaginal bleeding This is the most common sign that cancer is on board in your uterus, said Dr. Lee. In fact, abnormal bleeding happens in 90% of endometrial cancer cases, according to the National Cancer Institute. If you're postmenopausal and all of a sudden you find yourself needing panty protection again, that's not normal. "Women after menopause should not have further bleeding or even spotting," said Dr. Lee. Check in with your doctor if you are. In younger women, heavier than normal periods, periods that last longer than you're used to, or bleeding between periods could all be red flags, per the American Cancer Society. 2. Abnormal discharge It's normal to have some discharge from your vagina, but if the amount or color seems different than usual—or if you start spotting between periods and you never used to—it can't hurt to get checked out. If you've recently gone through menopause, you should also know that discharge isn't common after your periods stop for good, according to the American Cancer Society, so if you're still seeing some let your doctor know. 3. Constant pelvic pain Not everyone with endometrial cancer will have pain, but it can show up for some, especially if your cancer has been around for a while. "If the uterus has become enlarged due to the cancer, you may experience pain or cramping," said Dr. Lee. You may also find that it hurts to have sex or go to the bathroom, according to Johns Hopkins Medicine. But the hallmark is constant pelvic discomfort, which warrants a visit to your doctor. 4. Changes in your bathroom habits Does pressure in your pelvis have you heading for the ladies' room more often? Your bladder and bowels can be a good indicator of uterine problems, and that includes cancer. According to MyEndometrialCancerTeam, late stage endometrial cancer (once the cancer has grown and spread enough to affect the bladder and bowels) might make you need to go more often, have trouble getting urine out, or cause pain when you do go. You might also experience constipation, diarrhea, or trouble holding it in when you have to poop. 5. Unexplained weight loss If you're experiencing this symptom, it may mean your body's been dealing with a problem for a long time. "Weight loss is rare unless it's more advanced cancer," said Dr. Lee. That said, research in JAMA found that unintentional weight loss was associated with a much higher risk of a cancer diagnosis in the coming year. If the numbers are plummeting every time you step on a scale, especially if you have other gynecological symptoms, see your doctor ASAP. This story was originally published in 2017 and has since been lining of your uterus, your endometrium, is like a garden bed where a pregnancy can be planted. But other things sometimes grow there, too—including cancerous cells. Endometrial cancer affects more than 635,000 women in the US, but there's no standard screening test designed to catch it. "Pap tests don't check for or find endometrial cancer, and most women who get it have normal Paps," says Nita Karnik Lee, MD, associate professor of obstetrics and gynecology at the University of Chicago Medicine. In order to detect the disease, your doctor would have to order a transvaginal ultrasound or CT scan (along with a biopsy)—which of course isn't standard or advisable unless there's a strong reason to suspect you might have cancer. To protect yourself, start by knowing your risk factors: You can get endometrial cancer anytime, but it's most common between ages 45-74. Being overweight, having diabetes, and taking estrogen-only hormones ups your risk. So does going through menopause later than normal or having gotten your first period at an extra young age. (Looking to take back control of your health? Prevention has smart answers—get a FREE book when you subscribe today.) But the most important thing you can do, really, is to know the warning signs. (If you catch endometrial cancer early, it's highly curable.) Here are some worth bringing to your doc's attention: You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Yahoo
2 days ago
- Yahoo
As insurers axe Medicare plans, here's what advisors should know
Medicare Advantage enrollment has surged over the past two decades, but insurers' enthusiasm for the program is waning as they shift from expansion to profitability, cutting benefits and leaving unprofitable markets amid rising costs and lower government payments. Experts warn the changes could significantly impact older Americans who rely on Medicare Advantage — the private coverage sometimes called Medicare Part C — with considerable implications for retirement planning. Major insurers, including Humana, CVS Health Aetna and UnitedHealthcare, have all announced plans to scale back their Medicare Advantage operations in 2025 and 2026. Last May, CVS CFO Tom Cowhey said that the insurer could drop 1 in 10 — or roughly 600,000 — of its Medicare Advantage members by the end of 2025 in an effort to improve margins. READ MORE:A health care planning checklist for financial advisorsNew report reveals employees are underprepared for retirement and healthcare costsRetiree health care costs are climbing: What advisors need to knowLong-term care costs can derail retirement plans. Here's how to manage them "The goal for next year is margin over membership," Cowhey said. "Could we lose up to 10% of our existing Medicare members next year? That's entirely possible. And that's OK, because we need to get this business back on track." Humana has followed suit, announcing plans earlier this year to drop approximately 550,000 Medicare Advantage members by the end of 2025. UnitedHealthcare, which until recently has pushed to expand its Medicare Advantage membership, announced plans last month to drop more than 600,000 members by the end of 2026. "We are seeing higher-than-expected medical cost increases, particularly in outpatient care," UnitedHealthcare CEO Tim Noel said on the company's second-quarter earnings call. "The American health system's long-standing cost problem is accelerating." Together, Humana, CVS Health Aetna and UnitedHealthcare provide coverage to 58% of all Medicare Advantage beneficiaries, nearly 20 million people in total, according to KFF, a nonprofit health policy research, polling and news organization. Medicare Advantage plans gained popularity through $0 monthly premiums and expanded benefits compared to traditional Medicare. The program appealed to healthy beneficiaries and, until recently, delivered strong profits for insurers through generous government payments and upcoding practices. But rising medical costs and tighter oversight are pressuring margins, prompting some insurers to rethink their approach. Medicare experts like Melinda Caughill, the co-founder of 65 Incorporated, say that the shift could have major implications for financial advisors and the retirees they serve. Two possibilities for Medicare Advantage members Advisors should understand the two paths that could shape the experience of retirees enrolled in Medicare Advantage plans. For beneficiaries who remain on Medicare Advantage plans going forward, they're likely to see fewer benefits, higher costs in the form of premiums and copays and greater prior authorization requirements. "Prior Authorization means your doctor is not in charge of your health care needs," Caughill said. "Your doctor just advocates for you to an insurance company. Ultimately, the insurance company decides what you get or what you don't get." Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023, according to KFF. The Centers for Medicare and Medicaid Services, meanwhile, conducted fewer than 400,000 prior authorization reviews for traditional Medicare beneficiaries in that same time period. Nearly all Medicare Advantage enrollees (99%) must get prior authorization for certain services — typically high-cost care like inpatient hospital stays, skilled nursing facility care and chemotherapy. Once retirees enroll in a Medicare Advantage plan, leaving it isn't always simple. In most cases, beneficiaries can only switch back to traditional Medicare during specific enrollment periods, and doing so often means losing access to certain supplemental coverage options. Medigap policies, which help cover out-of-pocket costs under original Medicare, may require medical underwriting if purchased after the initial enrollment window — making it more expensive or, in some cases, even impossible for older or less healthy individuals to qualify. For many retirees, that creates a barrier to exiting a Medicare Advantage plan once they're already in it. For the small number of members who are dropped from their plans, Caughill calls the next step the "nuclear option." "When you are dropped from a Medicare Advantage policy based on no action or choice of your own, you get a Medicare do-over, meaning you can get a Medigap policy with no medical underwriting," Caughill said. While Medigap plans aren't strictly necessary, they can help cover costs that traditional Medicare doesn't. "You can get original Medicare by itself, but then that means you'll pay 20% of every bill with no spending limit in sight. But astonishingly, the number of people who wind up doing that when they're really sick is so huge that the government wrote a study on it, because they'd rather pay 20% of everything and at least get the care they need than remain on Medicare Advantage," Caughill said. "So people need to understand that these decisions are very often long-lasting. You can't just all of a sudden say, 'Ooh, here comes open enrollment, Oct. 15 through Dec. 7, and now we'll fix everything.' It's a lot more complicated than that. It's a lot more permanent than that." Why some advisors urge clients to avoid Medicare Advantage For many financial advisors guiding older clients, the advice is clear: Steer clear of Medicare Advantage from the outset. Carolyn McClanahan, a physician and founder of Life Planning Partners in Jacksonville, Florida, tells clients to think twice before signing up. The allure of Medicare Advantage often comes from lower upfront costs and extra perks — things like gym memberships or dental coverage. "When you are healthy, you don't have any problem with [Medicare Advantage] because you don't need to access health care often. The insurers are happy with that crowd because they are making money," McClanahan said. The picture changes dramatically when health issues arise. Along with prior authorization requirements, insurers often narrow their networks further as expenses rise, making it harder for patients to find doctors. "Once you get sick and have to experience the limitations of [Medicare Advantage], you wish you were on traditional Medicare," McClanahan said. "But because you are sick, you will have a problem with the underwriting to get back on a Medigap policy." Caughill said it's crucial that advisors educate themselves on Medicare and incorporate it into their retirement planning. "I'm constantly on a soapbox with financial advisors to try to get them to care," Caughill said. "Because at some point, a financial advisor who doesn't care, who doesn't consider Medicare, … will have conversations with their best clients in 10 or 15 years [and say], 'Oh, you have all these unexpected medical costs now, and this skilled nursing facility stay is not covered. What are we going to do?'" "I get it. We all want to do just what we signed up for. But Medicare is, unfortunately, a prevalent part of retirement," she said. "You can't do retirement planning without considering the number one cost in retirement, which is health care, which in this country is Medicare."
Fast Company
3 days ago
- Fast Company
Man charged with cyberstalking family member of slain UnitedHealthcare CEO Brian Thompson
A New York man has been charged with cyberstalking a family member of UnitedHealthcare CEO Brian Thompson, allegedly leaving threatening voicemails that expressed glee about the insurance executive's killing, federal prosecutors said Wednesday. Shane Daley, 40, is accused of placing multiple calls to Thompson's family member after the shooting, justifying the killing and saying that the person deserved to die in a similar manner, according to a criminal complaint. Daley, of Galway, New York, a small town north of Albany, was arrested and had an initial court appearance Wednesday. He was released with GPS monitoring and is scheduled back in court Thursday afternoon, a spokesperson for the U.S. attorney's office in Albany said. Daley's attorney, Samuel Breslin, said they are reviewing the allegations and evidence. In a statement, Acting United States Attorney John A. Sarcone said that 'Brian Thompson was gunned down in midtown Manhattan. Daley, as alleged, gleefully welcomed this tragedy and did all that he could to increase the Thompson family's pain and suffering.' Thompson was fatally shot outside a hotel in New York City in December by a man who was angered over what he viewed as corporate greed, according to prosecutors. The suspect, Luigi Mangione, has pleaded not guilty. The killing of Thompson, who led one of the biggest health insurers in the U.S., resulted in a vast outpouring of public frustration with the country's health care system. Many Americans reacted to the shooting by relaying personal stories about difficult experiences with insurance companies. Mangione himself has been lionized as a sort of vigilante hero by those who are critical of the insurance industry.
